ProKidney Corp. Rings the Nasdaq Stock Market Opening Bell
ProKidney Corp. (Nasdaq: PROK), a leading clinical-stage cellular therapeutics company focused on chronic kidney disease (“CKD”), visits the Nasdaq MarketSite in Times Square to commemorate the closing of its business combination with Social Capital Suvretta Holdings Corp. III. In honor of the occasion, Pablo Legorreta, Chairman, and Tim Bertram, Founder and CEO of ProKidney, rings the Opening Bell.